Cancer drug is shown to prolong life in trial
Genentech's cancer drug Avastin prolonged the lives of patients with advanced lung cancer in a clinical trial, a result that sent its own shares and those of its parent, the Swiss company Roche,
Genentech's cancer drug Avastin prolonged the lives of patients with advanced lung cancer in a clinical trial, a result that sent its own shares and those of its parent, the Swiss company Roche,